Owens & Minor (NYSE:OMI) today reported third-quarter profits that beat the consensus forecast on Wall Street, but revenues were down year-over-year. The Mechanicsville, Va.-based healthcare logistics and medical supplies company reported profits of $1.2 million, or 2¢ per share, on sales of $2.40 billion for the three months ended Sept. 30, 2019, versus a loss of […]
Coloplast to keep interventional urology business
Coloplast (CPH:COLO-B) officials have decided to keep the company’s interventional urology business — about five months after confirming it was the subject of a strategic review. “After completing a thorough review, we have firmly concluded that the interventional urology business is core to our mission, and that retaining the business is the right decision to […]
Nevro launches Senza Omnia spinal cord stimulation system
Nevro (NYSE:NVRO) said today that it won FDA approval for and launched its Senza Omnia spinal cord stimulation system. The Senza Omnia is the first and only SCS system designed to deliver Nevro’s proprietary HF10 therapy, as well as other available SCS frequencies, Nevro said in a news release. Redwood City, Calif.–based Nevro’s Omnia system is […]
Philips launches next-gen vital signs monitor for early patient intervention
Royal Philips (NYSE:PHG) said today that it has initiated the U.S. launch of the EarlyVue VS30 monitor — meant to help clinicians catch problems with hospital patients early and prioritize treatments. The EarlyVue VS30 uses automated early warning scoring (EWS) to collect the vital signs and calculate the alerts to allow clinicians to identify subtle signs […]
Former Theranos CEO wrangles with FDA over missing emails
As she prepares to face a criminal trial over federal wire fraud charges, discredited Theranos founder Elizabeth Holmes is arguing with the FDA over missing emails, according to media reports. Lawyers for Holmes and former Theranos president Sunny Balwani used a hearing yesterday in federal court in Northern California to criticize the FDA for failing […]
Zimmer Biomet nearly triples bottom line growth in Q3
Zimmer Biomet (NYSE:ZBH) reported third-quarter results today that beat the consensus forecast on Wall Street. The Warsaw, Ind.–based orthopedic device giant reported profits of $432 million, or $2.08 per share, on sales of $1.89 billion for the three months ended Sept. 30, 2019, nearly tripling the bottom line and growing sales 3% compared with Q3 2018. […]
BD beats The Street on Q4 results
Becton Dickinson (NYSE:BDX) today reported fourth-quarter results that beat Wall Street analysts’ expectations. The Franklin Lakes, N.J.–based medtech company reported profits of $150 million, or $0.41 per share, on sales of $4.58 billion for the three months ended Sept. 20, 2019. BD lost -$135 million off $4.40 billion in revenue during the same quarter a year […]
FDA clears DiFusion’s spinal implant with new biomaterial
DiFusion said today that it won FDA 510(k) clearance for its Xiphos-ZF spinal interbody device, the first spinal implant developed from the biomaterial Zfuze. Zfuze is a new biomaterial that is said to elicit pro-reparative M2 macrophage response and significant reductions in Interleukin 1-Beta and Interleukin 6. Both IL1-Beta and IL6 are cytokine markers for prolonged […]
Fresenius Medical Care North America launches connected health platform
Fresenius (NYSE:FMS) recently announced that its Fresenius Medical Care North America (FMCNA) business has launched a connected health platform called TheHub. TheHub includes three integrated applications meant to enable people on dialysis, their care teams, and health providers to better collaborate. Fresenius officials see the system enhancing remote monitoring for people on home dialysis. The Trump administration […]
Minnetronix Medical picks president Jeremy Maniak as new CEO
Minnetronix Medical (St. Paul, Minn.) said today that current president Jeremy Maniak will take over as the company’s CEO in February 2020. The nine-year veteran of Minnetronix is slated to succeed the company’s founder Richard Nazarian. Nazarian founded Minnetronix in 1996 along with 3M veterans Dirk Smith and Jon Pierce, growing the medical device contract […]
Orthofix taps former Biomet, Medtronic executive as new CEO
Orthofix (NSDQ:OFIX) has appointed Jon Serbousek — a 30-year veteran of the medical device and biotech industries — as its new president and CEO. The Lewisville, Texas–based orthopedic device company announced the appointment on Nov. 1, saying it was effective immediately. Serbousek takes over for Brad Mason, who previously announced his plan to retire. Mason will […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 1549
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube